Researchers closer to early detection of Parkinson's disease

September 26, 2012

(—In collaboration with colleagues at Oxford, a team of researchers at Umeå University in Sweden has now further elaborated its discovery of a way to detect Parkinson's disease at an early stage, and applications in clinical care are not far away.

The project is an example of bridging the gap between basic and clinical research in care environments. The new findings are based on close cooperation between the medical chemist Ludmilla Morozova-Roche's and the Lars Forsgren's research teams at Umeå University and Jason Davis's team at Oxford University in the UK, who were primarily responsible for the chemical analyses. Their findings are now being published in the journal .

Parkinson's disease attacks the nervous system and, like many other diseases, is caused by proteins that lump together into so-called amyloid. Behind these new findings lies a discovery from the spring of 2011, when the Umeå scientists were able to determine endogenous antibodies against the most important , alpha-synuclein. These antibodies were seen as being able to function as a , thereby enabling early detection of the disease.

In the new article the discovery is elaborated further in the form of a simplified way to carefully measure the content of antibodies in a . With the newly developed method – this involves electrochemical analysis of 10 microliters of blood in just a few minutes – it is possible not only to see a clear difference between individuals with incipient Parkinson's disease and healthy controls but also to measure and establish the advance of the disease with great precision.

Explore further: New research works towards early diagnosis of Parkinson's disease

More information: T Bryan, X Luo, L Forsgren, L Morozova-Roche and JJ Davis. The robust electrochemical detection of a Parkinson's disease marker in whole blood sera, Chemical Science, DOI: 10.1039/c2sc21221h

Related Stories

How Parkinson's disease starts and spreads

April 16, 2012

Injection of a small amount of clumped protein triggers a cascade of events leading to a Parkinson's-like disease in mice, according to an article published online this week in the Journal of Experimental Medicine.

Shining light on amyloid protein nanostructures

August 14, 2012

Scientists from the MESA+ and MIRA research institutes at the University of Twente have developed a new method to gain insight into the composition of large macromolecular protein assemblies. Their method allows the determination ...

Recommended for you

A composite thread that varies in rigidity

October 27, 2016

EPFL scientists have developed a new type of composite thread that varies in stiffness depending on its temperature. Applications range from multifunctional robots to knitted casts, and even tunable medical devices.

Turning CO2 to stone

October 25, 2016

Earth has limits to the amount of carbon dioxide in its atmosphere before the environment as we know it starts to change. Too much CO2 absorbed by the oceans makes the water more acidic. Too much in the atmosphere warms the ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.